TABLE 2.
ACE-i | ARB | BB | CCB | Diuretic Agents | Total | |
---|---|---|---|---|---|---|
Monotherapy | 31,867 (55.8) | 8,462 (57.6) | 54,559 (55.2) | 18,772 (81.5) | 4,774 (66.3) | 113,136 (56.3) |
Combination | 12,268 (50.3) | 6,030 (45.9) | 4,808 (49.3) | 43 (33.9) | 4,438 (61.0) | 25,587 (50.4) |
Values are n (%).
Includes 200,787 patients (78.6%) with monotherapy and 54,714 patients (21.4%) with fixed-dose combination therapy. Reprinted with permission from Schulz et al. (35).
ACE-i = angiotensin-converting enzyme inhibitors; ARB = angiotensin II receptor antagonists; BB = beta-blocker; CCB = calcium-channel blocker.